Learn Mode
GDRX logo

GDRX - GoodRx Holdings Inc

23


$2.01

$0.05 (2.551%)
At market close

$2.04

$0.03 (1.343%)
After Hours 4/1/26, 8:40 PM
Stock Unlock LogoScore

3.50/5

General
Scores
Financials & KPIs
Dividends
Analyst
Insider
GDRX
Valuation Score
View as %

Stock Unlock Logo
Stock Unlock
$1.85$5.17AprJunAugOctDecFeb

1D
1W
1M
YTD
1Y
3Y
5Y
Max

Stock Profile
  • Market Cap
    $671.45M
  • Industry
    Health Care
  • EPS (TTM)
    $0.08
  • P/E (TTM)
    22.06
  • Div & Yield
    --
  • FCF Payout Ratio
    --
  • P/S (TTM)
    0.84
  • P/B
    1.09
  • Diluted Shares
    343.62M
  • Ex-Dividend
    --
  • Next Earnings
    05-05
  • Forward P/E
    5.82
  • Payout Ratio
    --
  • P/FCF (TTM)
    7.15
  • FCF Yield
    13.98%
  • Earnings Yield
    4.53%
  • 52 Week Range
3.50
Good
GoodRx Holdings Inc has grown revenue at 0.57% over the past year, which suggests sales are increasing. Also, it has more cash than current liabilities meaning it has enough cash to handle all its debts within the next year, if it wanted to.
Valuation Model
Key Score
4.00
Good
Management
2.00
Bad

Growth
2.00
Bad

Profitability
5.00
Very Good
Fin. Health
3.00
Average

Dividends
--
--

Analyst
5.00
Very Good
Insider Transactions
Explore Insider Tab
Buy
Sell
2020202120222023202420252026$0$95M$190M$285M$380M
Market News
Page 1 of 21
Form 8-K
Current report pursuant to Section 13 or 15(d)

Filed on 2026-03-27 16:19:53


Form SCHEDULE 13G/A
Unknown Form Type

Filed on 2026-03-27 09:31:05


Form 8-K
Current report pursuant to Section 13 or 15(d)

Filed on 2026-03-18 16:59:09


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-13 19:22:26


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-09 17:19:20


Form 8-K
Current report pursuant to Section 13 or 15(d)

Filed on 2026-03-06 16:38:47


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-05 20:11:56


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-05 20:09:58


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-05 20:08:22


Form 8-K
Current report pursuant to Section 13 or 15(d)

Filed on 2026-02-27 16:31:05


Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Filed on 2026-02-25 18:31:48


Form 10-K
Annual financials report pursuant to Section 13 or 15(d)

Filed on 2026-02-25 18:27:53

Page 1 of 21
Revenue
Earnings
Free Cash Flow
2022202320242025-$300M$0$300M$600M$900M
Price Targets
Go to Analyst Tab
These are one year price targets for: 2027-03-25
High:
$3.68
82.8%
Avg:
$2.87
42.9%
Low:
$1.92
-4.5%
(% change is relative to the current stock price: $2.01)
Analyst Recommendations
Go to Analyst Tab
3.57
Good
19%
Strong Buy (4)
29%
Buy (6)
43%
Hold (9)
10%
Sell (2)
0%
Strong Sell (0)
About
GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The company is headquartered in Santa Monica, California and currently employs 697 full-time employees. The company went IPO on 2020-09-23. The firm connects consumers, healthcare professionals, payers, pharmacy benefit managers (PBMs), pharma manufacturers, and retail pharmacies to make saving on medications easier. The firm's offerings include prescription marketplace and pharma manufacturer solutions. Its prescription marketplace consists of its prescription transactions offering and its supplemental subscription and telehealth offerings. Through its GoodRx Care platform, the Company offers consumers access to telehealth visits on a cash-pay basis outside of insurance. The firm partners with pharma manufacturers to advertise and integrate their affordability solutions into its platform. These solutions, provided by pharma manufacturers, include co-pay cards, patient assistance programs, care portals, and other savings options to ensure consumers can access their medications.
  • IPO Date
    2020-09-23
  • Industry
    Health Care
  • Total Employees
    697
  • Exchange
    Nasdaq Nms - Global Market
  • Reporting Currency
    USD
  • GICS
    Health Care Technology
  • GICS Sub
    Health Care Technology
  • GICS Sector
    Health Care
  • GICS Group
    Health Care Equipment & Services